Novel therapies for biliary cancers in BK5.erbB-2 mice

$335,975R01FY2004CANIH

University Of Texas Md Anderson Can Ctr, Houston TX

Investigators

John Digiovanni

Linked publications & trials

Paper 17575102 Paper 17440093 Paper 17013831 Paper 16061875

View original record on NIH RePORTER →

Novel therapies for biliary cancers in BK5.erbB-2 mice · GrantIndex